Description
Selank TP-7 is a specific liquid formulation of Selank developed under the TP-7 designation, a formulation code associated with the standardized liquid preparation of the tuftsin-derived heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro for intranasal research delivery. The TP-7 designation distinguishes this specific liquid formulation from standard lyophilized Selank; the peptide sequence and research mechanism are identical. Selank is studied for GABAergic positive allosteric modulation, serotonergic neurotransmitter system effects, and enkephalin degradation inhibition through enzyme activity modulation in CNS research models.
Storage and Handling
For optimal stability, store sealed product in a cool, dark, and dry environment. Refrigeration at 2-8C is recommended after first puncture or once the seal has been compromised. Do not freeze. Protect from light. Handle under aseptic laboratory conditions.
Compliance Notice
Selank TP-7 (Liquid) is supplied for laboratory research use only. It is not intended for human or veterinary use and carries no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms it will be used exclusively for controlled research by qualified personnel following appropriate institutional safety procedures.
